Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Surgery
|
July 24, 2024
Understanding delays to parathyroidectomy: A mixed-methods approach
Catherine Chen, Winnie Li, Kavya K Sanghavi, et al.
Nature Communications
|
October 14, 2022
Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
Paul K Paik, Jia Luo, Ni Ai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma
Marjorie G Zauderer, Anne S Tsao, Tao Dao, et al.
Disability and Rehabilitation
|
February 10, 2026
Developing a capability assessment tool for physiotherapists managing patients with blunt chest trauma
Ceri Battle, Jane Barnett, Steve Hiles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2024
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer
Noura J Choudhury, W Victoria Lai, Alex Makhnin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 27, 2022
POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC
Marina K Baine, Christopher A Febres-Aldana, Jason C Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 6, 2022
Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset
Christopher A Febres-Aldana, Jason C Chang, Ryan Ptashkin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 1, 2026
Durvalumab Consolidation in Limited-Stage SCLC: Outcomes by Prior Concurrent Chemoradiotherapy and Prophylactic Cranial Irradiation in the Phase 3 ADRIATIC Trial
Suresh Senan, Byoung Chul Cho, Konstantin K Laktionov, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 4, 2020
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization
Marina K Baine, Min-Shu Hsieh, W Victoria Lai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2018
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer
Kathryn C Arbour, Laura Mezquita, Niamh Long, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Surgery
|
July 24, 2024
Understanding delays to parathyroidectomy: A mixed-methods approach
Catherine Chen, Winnie Li, Kavya K Sanghavi, et al.
Nature Communications
|
October 14, 2022
Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
Paul K Paik, Jia Luo, Ni Ai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma
Marjorie G Zauderer, Anne S Tsao, Tao Dao, et al.
Disability and Rehabilitation
|
February 10, 2026
Developing a capability assessment tool for physiotherapists managing patients with blunt chest trauma
Ceri Battle, Jane Barnett, Steve Hiles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2024
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer
Noura J Choudhury, W Victoria Lai, Alex Makhnin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 27, 2022
POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC
Marina K Baine, Christopher A Febres-Aldana, Jason C Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 6, 2022
Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset
Christopher A Febres-Aldana, Jason C Chang, Ryan Ptashkin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 1, 2026
Durvalumab Consolidation in Limited-Stage SCLC: Outcomes by Prior Concurrent Chemoradiotherapy and Prophylactic Cranial Irradiation in the Phase 3 ADRIATIC Trial
Suresh Senan, Byoung Chul Cho, Konstantin K Laktionov, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 4, 2020
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization
Marina K Baine, Min-Shu Hsieh, W Victoria Lai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2018
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer
Kathryn C Arbour, Laura Mezquita, Niamh Long, et al.
Page
of 6